Skip to Main Content
Contact Us

Move Your Oncology Research Forward

At Catalyst Oncology, we’re committed to advancing the field of oncology research. With our extensive experience and expertise, we offer tailored solutions across all phases of oncology studies. Our deep understanding of the nuances within oncology, from preclinical research to late-phase trials, ensures that your research is in the hands of experts every step of the way.

Preclinical Research

Designed to be delivered as a standalone service or seamlessly paired with a full-service oncology clinical trial offering.

Preclinical Research
Early Phase Research

Catalyst Oncology supports the intricacies of and has the connections for first-in-human (FIH), Phase I and Phase II cancer studies.

Early Phase Research
Late Phase Research

We are able to move forward Phase II or Phase III studies across the globe with our network of skilled clinical trial professionals and patient recruitment experts.

Late Phase Research
Our Proven Track Record

As we move forward, Catalyst Oncology is dedicated to evolving and expanding our late-phase research capabilitie

80+ active contracts across 50+ clients 150+ oncology studies to date
A strong focus on early-phase development with fluency in Phase 1 trials
Expertise in solid tumors, understanding nuances in each indication
A commitment to preserving early-phase competencies while expanding late-phase capabilities

Progress Your Research with Catalyst Oncology

Let’s embark on this oncology research journey together. Learn more about how we can provide exceptional CRO and consulting support and services for your clinical studies.